“A new way to screen poor women for cervical cancer was introduced this month in El Salvador, using a test that was originally developed in China,” the New York Times reports. “The new test, called careHPV and made by Qiagen, a Dutch company, is a swab test for the DNA of the papillomaviruses that cause cancer,” the newspaper writes, noting a study published in the Lancet Oncology in 2008 found the test “was more than twice as sensitive” than the alternate method of “shining a light on the cervix and painting it with vinegar, which reveals precancerous lesions that can then be burned off with liquid nitrogen or carbon dioxide.” According to the New York Times, “The test worked even when women inserted the swabs themselves, which can be done at home and so is easier and faster than having them go to a clinic for visual inspections” (McNeil, 9/24).
Non Communicable Disease/Chronic Disease
“Some academics and non-profit organizations are skeptical of the motives of the increasing number of multinational companies who seek partnerships to address non-communicable diseases (NCDs),” Derek Yach, senior vice president of global health and agriculture policy at PepsiCo and former head of NCDs at WHO, writes in the Huffington Post’s “Impact” blog. He asks, “So how well is the private sector doing in tackling the rising pandemic of NCDs, which cause nearly two out of every three deaths in the world (80 percent of those in developing countries), the four main ones being cancer, cardiovascular disease, chronic respiratory disease and diabetes?” He continues, “The private sector is a major stakeholder in many ways — as employers; makers of food and medicines, sports gear and technology; as corporate citizens and consumers — and wants to be engaged in the global NCD dialogue. We deserve a seat at the table.”
“About 200 million people around the world use illegal drugs every year, and that may be taking a toll on health and death rates in various countries, says a report released Thursday in the Lancet,” the Los Angeles Times’ “Booster Shots” blog reports. According to the blog, “[t]he study, part of a series the journal is doing on addiction, offers a plethora of information about [the] use of opioids, amphetamines, cocaine and marijuana worldwide” (Stein, 1/5).
“In 2012 there will be a major strategic shift in global health, away from development and towards sustainability,” a Lancet editorial states. “Since 2000, the Millennium Development Goals (MDGs), driven by a macroeconomic diagnosis of global poverty, have focused on investment in a small number of diseases as the most effective approach to decrease poverty, … [b]ut this approach is now delivering diminishing returns,” because of emerging challenges such as non-communicable diseases (NCDs), climate change, and financial security, as well as a heightened focus on integration and accountability, the editorial says.
“Countries need to change their current mindset to successfully tackle non-communicable diseases (NCDs), the head of the United Nations World Health Organization (WHO) said [Monday], adding that governments will need to explore new approaches to prevent and treat these diseases, which have quickly become one of the most pressing issues in public health,” the U.N. News Centre reports (1/16). “In an opening speech to the annual WHO Executive Board meeting, Director-General Margaret Chan … urged the 34-member board to tackle the root causes of non-communicable diseases,” VOA News writes (Schlein, 1/16).
“Mental illness and drug abuse can wreak havoc in global societies and economies, and the U.N. General Assembly should devote a special session to the matter, global health experts said” in a PLoS Medicine article published on Tuesday, Agence France-Presse reports (1/17). “Mental, neurological, and substance use disorders (MNS) … are leading contributors to the global burden of disease and profoundly impact the social and economic well-being of individuals and communities,” a PLoS press release states, adding, “Yet the majority of people affected by MNS disorders globally do not have access to evidence-based interventions and many experience discrimination and abuses of their human rights” (1/17).
“While the U.S. military has formally withdrawn from Iraq, doctors and residents of Fallujah are blaming weapons like depleted uranium and white phosphorous used during two devastating U.S. attacks on Fallujah in 2004 for what are being described as ‘catastrophic’ levels of birth defects and abnormalities,” Al Jazeera reports. Samira Alani, a pediatric specialist at Fallujah General Hospital, “told Al Jazeera she had personally logged 677 cases of birth defects since October 2009,” the news service notes, adding, “Just eight days later when Al Jazeera visited the city on December 29, that number had already risen to 699.”
Reuters examines cancer in Africa, writing, “Most of Africa’s around 2,000 languages have no word for cancer. The common perception in both developing and developed countries is that it’s a disease of the wealthy world, where high-fat, processed-food diets, alcohol, smoking and sedentary lifestyles fuel tumor growth.” However, according to the news service, sub-Saharan Africa will see an estimated one million new cancer cases this year — “a number predicted to double to two million a year in the next decade,” and, “[b]y 2030, according to predictions from the [WHO], 70 percent of the world’s cancer burden will be in poor countries.”
“Bacteria, viruses and parasites cause around two million cases of cancer in the world each year, experts believe,” the Press Association/Guardian reports. According to the news service, “Scientists carried out a statistical analysis of cancer incidence to calculate that around 16 percent of all cancers diagnosed in 2008 were infection-related,” and “[t]he proportion of cancers linked to infection was three times higher in developing countries than in developed ones.”
International Community, U.S. Should Increase Resources, Mandate For Fighting NCDs In Developing World
In this Foreign Affairs essay, Thomas Bollyky, a senior fellow for global health, economics and development at the Council on Foreign Relations, examines the increase of non-communicable diseases (NCDs) in the developing world, writing, “When most people in developed countries think of the biggest health challenges confronting the developing world, they envision a small boy in a rural, dusty village beset by an exotic parasite or bacterial blight,” but “NCDs in developing countries are occurring more rapidly, arising in younger people, and leading to far worse health outcomes than ever seen in developed countries.” He notes, “According to the World Economic Forum’s 2010 Global Risks report, these diseases pose a greater threat to global economic development than fiscal crises, natural disasters, corruption, or infectious disease.”